The Influence of the Gut Microbiome on Obesity in Adults and the Role of Probiotics, Prebiotics, and Synbiotics for Weight Loss

Antoine Aoun, Fatima Darwish, Natacha Hamod, Antoine Aoun, Fatima Darwish, Natacha Hamod

Abstract

The link between the gut microbiome and obesity is not well defined. Understanding of the role of the gut microbiome in weight and health management may lead to future revolutionary changes for treating obesity. This review examined the relationship between obesity and the gut microbiome, and the role of probiotics, prebiotics, and synbiotics for preventing and treating obesity. We used PubMed and Google Scholar to collect appropriate articles for the review. We showed that the gut microbiome has an impact on nutrient metabolism and energy expenditure. Moreover, different modalities of obesity treatment have been shown to change the diversity and composition of the gut microbiome; this raises questions about the role these changes may play in weight loss. In addition, studies have shown that supplementation with probiotics, prebiotics, and synbiotics may alter the secretion of hormones, neurotransmitters, and inflammatory factors, thus preventing food intake triggers that lead to weight gain. Further clinical studies are needed to better understand how different species of bacteria in the gut microbiome may affect weight gain, and to determine the most appropriate doses, compositions, and regimens of probiotics, prebiotics, and synbiotics supplementation for long-term weight control.

Keywords: gut microbiome; obesity; prebiotics; probiotics; weight loss.

Conflict of interest statement

AUTHOR DISCLOSURE STATEMENT The authors declare no conflict of interest.

Copyright © 2020 by The Korean Society of Food Science and Nutrition. All rights Reserved.

Figures

Fig. 1
Fig. 1
Process of inclusion/exclusion of studies on gut microbiome and obesity, and on the role of probiotics, prebiotics, and synbiotics in weight loss.

References

    1. Agus A, Denizot J, Thévenot J, Martinez-Medina M, Massier S, Sauvanet P, et al. Western diet induces a shift in microbiota composition enhancing susceptibility to adherent-invasive E. coli infection and intestinal inflammation. Sci Rep. 2016;6:19032. doi: 10.1038/srep19032. doi: 10.1038/srep19032.
    1. Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA, et al. Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc. 2018;50:747–757. doi: 10.1249/MSS.0000000000001495.
    1. Aron-Wisnewsky J, Prifti E, Belda E, Ichou F, Kayser BD, Dao MC, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2019;68:70–82. doi: 10.1136/gutjnl-2018-316103.
    1. Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG. 2016;123:983–993. doi: 10.1111/1471-0528.13601.
    1. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718–15723. doi: 10.1073/pnas.0407076101.
    1. Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis. 2016;15:108. doi: 10.1186/s12944-016-0278-4. doi: 10.1186/s12944-016-0278-4.
    1. Beserra BT, Fernandes R, do Rosario VA, Mocellin MC, Kuntz MG, Trindade EB. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin Nutr. 2015;34:845–858. doi: 10.1016/j.clnu.2014.10.004.
    1. Brooks L, Viardot A, Tsakmaki A, Stolarczyk E, Howard JK, Cani PD, et al. Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety. Mol Metab. 2016;6:48–60. doi: 10.1016/j.molmet.2016.10.011.
    1. Brusaferro A, Cozzali R, Orabona C, Biscarini A, Farinelli E, Cavalli E, et al. Is it time to use probiotics to prevent or treat obesity? Nutrients. 2018;10:1613. doi: 10.3390/nu10111613. doi: 10.3390/nu10111613.
    1. Çelik MN, Ünlü Söğüt M. Probiotics improve chemerin levels and metabolic syndrome parameters in obese rats. Balkan Med J. 2019;36:270–275. doi: 10.4274/balkanmedj.galenos.2019.2019.2.61.
    1. Cerdó T, García-Santos JA, Bermúdez MG, Campoy C. The role of probiotics and prebiotics in the prevention and treatment of obesity. Nutrients. 2019;11:635. doi: 10.3390/nu11030635. doi: 10.3390/nu11030635.
    1. Chambers ES, Preston T, Frost G, Morrison DJ. Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health. Curr Nutr Rep. 2018;7:198–206. doi: 10.1007/s13668-018-0248-8.
    1. Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC, et al. Next generation probiotics in disease amelioration. J Food Drug Anal. 2019;27:615–622. doi: 10.1016/j.jfda.2018.12.011.
    1. Chang CJ, Lu CC, Lin CS, Martel J, Ko YF, Ojcius DM, et al. Antrodia cinnamomea reduces obesity and modulates the gut microbiota in high-fat diet-fed mice. Int J Obes. 2018;42:231–243. doi: 10.1038/ijo.2017.149.
    1. Dao MC, Clément K. Gut microbiota and obesity: concepts relevant to clinical care. Eur J Intern Med. 2018;48:18–24. doi: 10.1016/j.ejim.2017.10.005.
    1. Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65:426–436. doi: 10.1136/gutjnl-2014-308778.
    1. Davis LM, Martínez I, Walter J, Goin C, Hutkins RW. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One. 2011;6:e25200. doi: 10.1371/journal.pone.0025200. doi: 10.1371/journal.pone.0025200.
    1. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107:14691–14696. doi: 10.1073/pnas.1005963107.
    1. Duca I, Rusu F, Chira A, Dumitrascu DL. Gut microbiota and body weight-a review. Psychol Topics. 2018;27:33–53. doi: 10.31820/pt.27.1.3.
    1. Fernandes J, Su W, Rahat-Rozenbloom S, Wolever TM, Comelli EM. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes. 2014;4:e121. doi: 10.1038/nutd.2014.23. doi: 10.1038/nutd.2014.23.
    1. Fischer N, Relman DA. Clostridium difficile, aging, and the gut: can microbiome rejuvenation keep us young and healthy? J Infect Dis. 2018;217:174–176. doi: 10.1093/infdis/jix417.
    1. Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. 2018;362:776–780. doi: 10.1126/science.aau5812.
    1. Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: metabolism and perspective in obesity. Gut Microbes. 2018;9:308–325. doi: 10.1080/19490976.2018.1465157.
    1. Guirro M, Costa A, Gual-Grau A, Herrero P, Torrell H, Canela N, et al. Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: a multiomics approach. PLoS One. 2019;14:e0218143. doi: 10.1371/journal.pone.0218143. https: //.
    1. Hamilton MK, Raybould HE. Bugs, guts and brains, and the regulation of food intake and body weight. Int J Obes Suppl. 2016;6:S8–S14. doi: 10.1038/ijosup.2016.3.
    1. He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 2017;7:54. doi: 10.1186/s13578-017-0183-1. doi: 10.1186/s13578-017-0183-1.
    1. Hjorth MF, Roager HM, Larsen TM, Poulsen SK, Licht TR, Bahl MI, et al. Pre-treatment microbial Prevotella-to-Bacteroides ratio, determines body fat loss success during a 6-month randomized controlled diet intervention. Int J Obes. 2018;42:580–583. doi: 10.1038/ijo.2017.220.
    1. Ji Y, Chung YM, Park S, Jeong D, Kim B, Holzapfel WH. Dose-dependent and strain-dependent anti-obesity effects of Lactobacillus sakei in a diet induced obese murine model. PeerJ. 2019a;7:e6651. doi: 10.7717/peerj.6651. doi: 10.7717/peerj.6651.
    1. Ji Y, Park S, Chung Y, Kim B, Park H, Huang E, et al. Amelioration of obesity-related biomarkers by Lactobacillus sakei CJLS03 in a high-fat diet-induced obese murine model. Sci Rep. 2019b;9:6821. doi: 10.1038/s41598-019-43092-y. doi: 10.1038/s41598-019-43092-y.
    1. John GK, Mullin GE. The gut microbiome and obesity. Curr Oncol Rep. 2016;18:45. doi: 10.1007/s11912-016-0528-7. doi: 10.1007/s11912-016-0528-7.
    1. Kasai C, Sugimoto K, Moritani I, Tanaka J, Oya Y, Inoue H, et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 2015;15:100. doi: 10.1186/s12876-015-0330-2. doi: 10.1186/s12876-015-0330-2.
    1. Kong C, Gao R, Yan X, Huang L, Qin H. Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet. Nutrition. 2019;60:175–184. doi: 10.1016/j.nut.2018.10.002.
    1. Koutnikova H, Genser B, Monteiro-Sepulveda M, Faurie JM, Rizkalla S, Schrezenmeir J, et al. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019;9:e017995. doi: 10.1136/bmjopen-2017-017995. doi: 10.1136/bmjopen-2017-017995.
    1. Krumbeck JA, Rasmussen HE, Hutkins RW, Clarke J, Shawron K, Keshavarzian A, et al. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome. 2018;6:121. doi: 10.1186/s40168-018-0494-4. doi: 10.1186/s40168-018-0494-4.
    1. Lankelma JM, Nieuwdorp M, de Vos WM, Wiersinga WJ. The gut microbiota in internal medicine: implications for health and disease. Neth J Med. 2015;73:61–68.
    1. Le Roy CI, Bowyer RCE, Castillo-Fernandez JE, Pallister T, Menni C, Steves CJ, et al. Dissecting the role of the gut microbiota and diet on visceral fat mass accumulation. Sci Rep. 2019a;9:9758. doi: 10.1038/s41598-019-46193-w. doi: 10.1038/s41598-019-46193-w.
    1. Le Roy CI, Woodward MJ, Ellis RJ, La Ragione RM, Claus SP. Antibiotic treatment triggers gut dysbiosis and modulates metabolism in a chicken model of gastro-intestinal infection. BMC Vet Res. 2019b;15:37. doi: 10.1186/s12917-018-1761-0. doi: 10.1186/s12917-018-1761-0.
    1. Leong KSW, Derraik JGB, Hofman PL, Cutfield WS. Antibiotics, gut microbiome and obesity. Clin Endocrinol. 2018;88:185–200. doi: 10.1111/cen.13495.
    1. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol. 2010;26:5–11. doi: 10.1097/MOG.0b013e328333d751.
    1. Li Z, Yi CX, Katiraei S, Kooijman S, Zhou E, Chung CK, et al. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut. 2018;67:1269–1279. doi: 10.1136/gutjnl-2017-314050.
    1. Lin HV, Frassetto A, Kowalik EJ, Jr, Nawrocki AR, Lu MM, Kosinski JR, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One. 2012;7:e35240. doi: 10.1371/journal.pone.0035240. doi: 10.1371/journal.pone.0035240.
    1. Liou AP, Paziuk M, Luevano JM, Jr, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178ra41. doi: 10.1126/scitranslmed.3005687. doi: 10.1126/scitranslmed.3005687.
    1. Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, et al. Gut microbiome and serum metabolome alterations in obesity and after weight- loss intervention. Nat Med. 2017;23:859–868. doi: 10.1038/nm.4358.
    1. Lv Y, Qin X, Jia H, Chen S, Sun W, Wang X. The association between gut microbiota composition and BMI in Chinese male college students, as analysed by next-generation sequencing. Br J Nutr. 2019;122:986–995. doi: 10.1017/S0007114519001909.
    1. Maniar K, Moideen A, Bhattacharyya R, Banerjee D. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: a hypothesis. Med Hypotheses. 2017;104:117–120. doi: 10.1016/j.mehy.2017.06.001.
    1. Mazloom K, Siddiqi I, Covasa M. Probiotics: how effective are they in the fight against obesity? Nutrients. 2019;11:258. doi: 10.3390/nu11020258. https:// .
    1. McClave SA, Martindale RG. Why do current strategies for optimal nutritional therapy neglect the microbiome? Nutrition. 2019;60:100–105. doi: 10.1016/j.nut.2018.09.024.
    1. Menni C, Jackson MA, Pallister T, Steves CJ, Spector TD, Valdes AM. Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain. Int J Obes. 2017;41:1099–1105. doi: 10.1038/ijo.2017.66.
    1. Mohajeri MH, Brummer RJM, Rastall RA, Weersma RK, Harmsen HJM, Faas M, et al. The role of the microbiome for human health: from basic science to clinical applications. Eur J Nutr. 2018;57:1–14. doi: 10.1007/s00394-018-1703-4.
    1. Noble EE, Hsu TM, Kanoski SE. Gut to brain dysbiosis: mechanisms linking Western diet consumption, the microbiome, and cognitive impairment. Front Behav Neurosci. 2017;11:9. doi: 10.3389/fnbeh.2017.00009. doi: 10.3389/fnbeh.2017.00009.
    1. Okeke F, Roland BC, Mullin GE. The role of the gut microbiome in the pathogenesis and treatment of obesity. Glob Adv Health Med. 2014;3:44–57. doi: 10.7453/gahmj.2014.018.
    1. Oriach CS, Robertson RC, Stanton C, Cryan JF, Dinan TG. Food for thought: the role of nutrition in the microbiota-gut-brain axis. Clin Nutr Exp. 2016;6:25–38. doi: 10.1016/j.yclnex.2016.01.003.
    1. Osterberg KL, Boutagy NE, McMillan RP, Stevens JR, Frisard MI, Kavanaugh JW, et al. Probiotic supplementation attenuates increases in body mass and fat mass during high-fat diet in healthy young adults. Obesity. 2015;23:2364–2370. doi: 10.1002/oby.21230.
    1. Park S, Ji Y, Jung HY, Park H, Kang J, Choi SH, et al. Lactobacillus plantarum HAC01 regulates gut microbiota and adipose tissue accumulation in a diet-induced obesity murine model. Appl Microbiol Biotechnol. 2017;101:1605–1614. doi: 10.1007/s00253-016-7953-2.
    1. Plaza-Diaz J, Gomez-Llorente C, Abadia-Molina F, Saez-Lara MJ, Campaña-Martin L, Muñoz-Quezada S, et al. Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats. PLoS One. 2014;9:e98401. doi: 10.1371/journal.pone.0098401. doi: 10.1371/journal.pone.0098401.
    1. Podolsky SH. Historical perspective on the rise and fall and rise of antibiotics and human weight gain. Ann Intern Med. 2017;166:133–138. doi: 10.7326/M16-1855.
    1. Qian L, Gao R, Huang J, Qin H. Supplementation of triple viable probiotics combined with dietary intervention is associated with gut microbial improvement in humans on a high-fat diet. Exp Ther Med. 2019;18:2262–2270. doi: 10.3892/etm.2019.7801.
    1. Rastelli M, Knauf C, Cani PD. Gut microbes and health: a focus on the mechanisms linking microbes, obesity, and related disorders. Obesity. 2018;26:792–800. doi: 10.1002/oby.22175.
    1. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341:1241214. doi: 10.1126/science.1241214. doi: 10.1126/science.1241214.
    1. Sanmiguel C, Gupta A, Mayer EA. Gut microbiome and obesity: a plausible explanation for obesity. Curr Obes Rep. 2015;4:250–261. doi: 10.1007/s13679-015-0152-0.
    1. Santacruz A, Marcos A, Wärnberg J, Martí A, Martin-Matillas M, Campoy C, et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity. 2009;17:1906–1915. doi: 10.1038/oby.2009.112.
    1. Schneeberger M, Everard A, Gómez-Valadés A, Matamoros S, Ramírez S, Delzenne NM, et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 2015;5:16643. doi: 10.1038/srep16643. doi: 10.1038/srep16643.
    1. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity. 2010;18:190–195. doi: 10.1038/oby.2009.167.
    1. Simpson HL, Campbell BJ. Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther. 2015;42:158–179. doi: 10.1111/apt.13248.
    1. Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019;13:3–15. doi: 10.1080/17474124.2019.1543023.
    1. Sivamaruthi BS, Kesika P, Suganthy N, Chaiyasut C. A review on role of microbiome in obesity and antiobesity properties of probiotic supplements. BioMed Res Int. 2019;2019:3291367. doi: 10.1155/2019/3291367. doi: 10.1155/2019/3291367.
    1. Stark CM, Susi A, Emerick J, Nylund CM. Antibiotic and acid-suppression medications during early childhood are associated with obesity. Gut. 2019;68:62–69. doi: 10.1136/gutjnl-2017-314971.
    1. Stephens RW, Arhire L, Covasa M. Gut microbiota: from microorganisms to metabolic organ influencing obesity. Obesity. 2018;26:801–809. doi: 10.1002/oby.22179.
    1. Tandon D, Haque MM, Gote M, Jain M, Bhaduri A, Dubey AK, et al. A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora. Sci Rep. 2019;9:5473. doi: 10.1038/s41598-019-41837-3. doi: 10.1038/s41598-019-41837-3.
    1. Turroni F, Ventura M, Buttó LF, Duranti S, O'Toole PW, Motherway MO, et al. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci. 2014;71:183–203. doi: 10.1007/s00018-013-1318-0.
    1. Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. doi: 10.1136/bmj.k2179. doi: 10.1136/bmj.k2179.
    1. Wang J, Liu S, Wang H, Xiao S, Li C, Li Y, et al. Xanthophyllomyces dendrorhous-derived astaxanthin regulates lipid metabolism and gut microbiota in obese mice induced by a high-fat diet. Mar Drugs. 2019a;17:337. doi: 10.3390/md17060337. doi: 10.3390/md17060337.
    1. Wang ZB, Xin SS, Ding LN, Ding WY, Hou YL, Liu CQ, et al. The potential role of probiotics in controlling overweight/obesity and associated metabolic parameters in adults: a systematic review and meta-analysis. Evid Based Complementary Altern Med. 2019b;2019:3862971. doi: 10.1155/2019/3862971. doi: 10.1155/2019/3862971.
    1. Whisner CM, Maldonado J, Dente B, Krajmalnik-Brown R, Bruening M. Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross- sectional study. BMC Microbiol. 2018;18:210. doi: 10.1186/s12866-018-1362-x. doi: 10.1186/s12866-018-1362-x.
    1. Wiese M, Bashmakov Y, Chalyk N, Nielsen DS, Krych Ł, Kot W, et al. Prebiotic effect of lycopene and dark chocolate on gut microbiome with systemic changes in liver metabolism, skeletal muscles and skin in moderately obese persons. Biomed Res Int. 2019;2019:4625279. doi: 10.1155/2019/4625279. doi: 10.1155/2019/4625279.
    1. Wilkins LJ, Monga M, Miller AW. Defining dysbiosis for a cluster of chronic diseases. Sci Rep. 2019;9:12918. doi: 10.1038/s41598-019-49452-y. doi: 10.1038/s41598-019-49452-y.
    1. Wu TR, Lin CS, Chang CJ, Lin TL, Martel J, Ko YF, et al. Gut commensal nParabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut. 2019;68:248–262. doi: 10.1136/gutjnl-2017-315458.
    1. Zhang N, Ju Z, Zuo T. Time for food: the impact of diet on gut microbiota and human health. Nutrition. 2018;51(52):80–85. doi: 10.1016/j.nut.2017.12.005.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren